SCHEMBL17035154

SCHEMBL17035154

N#Cc1ccc(-c2nc3cc(Cl)ccc3c3c2cc(-c2ccccc2)c2ccccc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.45
DHODH Q02127 1/20 0.43
PDE10A Q9Y233 2/20 0.42
ADORA1 P30542 2/20 0.41
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SQOR Q9Y6N5 1/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ADORA2A P29274 2/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
CNR1 P21554 1/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035152 0.86 ABCG2 (0.43) KMT2AKDM4EALDH1A1LMNAADORA2A
SCHEMBL17037303 0.85 ABCG2 (0.48) KMT2AKDM4EALDH1A1LMNAADORA2A
SCHEMBL17037772 0.80 ADORA2A (0.43) KMT2AKDM4EALDH1A1LMNAADORA2A
SCHEMBL17037301 0.80 CYP11B2 (0.54) KMT2ADHODHADORA1ALDH1A1ADORA2A
SCHEMBL17037302 0.80 ADORA2A (0.40) KMT2APDE10AKDM4EALDH1A1LMNA
SCHEMBL20967864 0.80 ALOX5 (0.47) KMT2AADORA1ALDH1A1SQORLMNA
SCHEMBL24422558 0.78 ALDH1A1 (0.45) KMT2AKDM4EALDH1A1LMNAGAA
SCHEMBL24422922 0.78 ALDH1A1 (0.45) KMT2AKDM4EALDH1A1LMNAGAA
SCHEMBL20967898 0.77 ALOX5 (0.40) KMT2AADORA1ALDH1A1SQORLMNA
SCHEMBL21933898 0.76 ADORA1 (0.49) KMT2ADHODHADORA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KMT2A 2092/4885DHODH 2312/4885PDE10A 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.